Oncotarget

Corrections:

Correction: Procollagen-lysine 2-oxoglutarate 5-dioxygenase 2 promotes hypoxia-induced glioma migration and invasion

PDF  |  How to cite

Oncotarget. 2021; 12:1442-1443. https://doi.org/10.18632/oncotarget.28003

Metrics: PDF 983 views  |   ?  

Yangyang Xu1, Lin Zhang2, Yuzhen Wei1,3, Xin Zhang1, Ran Xu1, Mingzhi Han1, Bing Huang1, Anjing Chen1, Wenjie Li1, Qing Zhang1, Gang Li1, Jian Wang1,4, Peng Zhao1 and Xingang Li1

1 Department of Neurosurgery, Qilu Hospital of Shandong University and Brain Science Research Institute, Shandong University, Jinan 250012, China
2 Institute of Basic Medical Sciences, Qilu Hospital of Shandong University, Jinan 250012, China
3 Department of Neurosurgery, Jining No.1 People’s Hospital, Jining 272011, China
4 Department of Biomedicine, University of Bergen, 5009 Bergen, Norway

Published: July 06, 2021

Copyright: © 2021 Xu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has been corrected: Due to errors during the assembly of Figure 5B, incorrect images were placed in row 1, panel 4 and row 2, panel 4. The corrected Figure 5B, produced using the original data, is shown below. The authors declare that these corrections do not change the results or conclusions of this paper.

Original article: Oncotarget. 2017; 8:23401–23413. DOI: https://doi.org/10.18632/oncotarget.15581.

Figure 5: Treatment with FAK inhibitor attenuates U87 and U251 cell migration and invasion. (B) Representative images and quantification (cell number/field) of transwell migration assays for parental U87 and U251 cells treated with TAE226 (5 μM) under normoxic and hypoxic conditions (Scale bars, 50 μm).


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28003